Atlas Trials

Axalimogene Filolisbac (ADXS11-001) High Dose in Women With Human Papillomavirus (HPV) + Cervical Cancer

Clinical trial NCT02164461 · COMPLETED

Trial details

NCT number
NCT02164461
Sponsor
Advaxis, Inc.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Effects of ImmunotherapyMetastatic/Recurrent Cervical CancerCervical AdenocarcinomaCervical Adenosquamous Cell CarcinomaCervical Squamous Cell CarcinomaCervical Small Cell CarcinomaStage III Cervical CancerStage IVA Cervical CancerStage IVB Cervical Cancer
Start date
2015-03-04
Primary completion
2017-03-08
Enrollment
12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.